IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sunrest Lifescience IPO is a Fixed Price IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Mark Corporate Advisors is the merchant banker of Sunrest Lifescience IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th June 2023.
Sunrest Lifescience IPO open date is 7th November 2023 and close date is 9th November 2023. IPO Allotment Date is 15th November 2023 and Listing date is 20th November 2023.
IPO
Size:
₹ 10.85 Cr.
Avg IPO Size (Sector Based)
: ₹
21.21 cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Mark Corporate
SME
IPO by BRLM so far:
10
City:
Ahmedabad
SME
IPO so far:
174
Revenue (annualised):
₹
22.56
cr. 
PE
Ratio:
12.00x
Average Sector PE Ratio: 20.29x
Sunrest Lifescience IPO size is ₹ 10.85 Cr. with IPO price of ₹ 84.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Mark Corporate Advisors Private Limited is the book-running lead manager of the Sunrest Lifescience IPO. Skyline Financial Services Private Limited is the Registrar and Market Maker is Svcm Securities Private Limited for Sunrest Lifescience IPO.
Sunrest Lifescience IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Sunrest Lifescience IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste.. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Sunrest Lifescience IPO size is ₹ 10.85 Cr. with fresh issue size of ₹ 10.85 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Sunrest Lifescience IPO is expected to be 15th November 2023, after the finalization of basis of allotment. Investors can check Sunrest Lifescience IPO allotment status on the registrars website, Skyline Financial Services Private Limited. Sunrest Lifescience IPO refund dates are 16th November 2023.
Sunrest Lifescience IPO is expected to be listed on 20th November 2023.
The upper price band for the Sunrest Lifescience IPO is set at ₹ 84.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Sunrest Lifescience IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Sunrest Lifescience IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 9th November 2023. After submission, funds are blocked until the basis of allotment of Sunrest Lifescience IPO is finalised.
The merchant banker for Sunrest Lifescience IPO is Mark Corporate Advisors Private Limited . Mark Corporate Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Sunrest Lifescience IPO RHP for further details.
The registrar for Sunrest Lifescience IPO is Skyline Financial Services Private Limited. Investors can go to Skyline Financial Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Sunrest Lifescience IPO through their official website or helpline.
Sunrest Lifescience IPO was subscribed 48.54 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 10.85 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.21 Cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Mark Corporate
SME
IPO by BRLM so far:
10
City:
Ahmedabad
SME
IPO so far:
174
Revenue (annualised):
₹ 22.52 cr.
PE
Ratio:
12.00x
Average Sector PE Ratio: 20.29x
Sunrest Lifescience IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sunrest Lifescience Financial Review Page
Merchant Banker(s) of Sunrest Lifescience IPO: Mark Corporate Advisors Private Limited
Sunrest Lifescience IPO subscription was 48.54 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sunrest Lifescience IPO listed at a listing price of 79.80 against the offer price of 84.00.
The current market price of Sunrest Lifescience is 53.50.
Why Us?
